Rosuvastatin alters the genetic composition of the human gut microbiome.

ABSTRACT: The gut microbiome contributes to the variation of blood lipid levels, and secondary bile acids are associated with the effect of statins. Yet, our knowledge of how statins, one of our most common drug groups, affect the human microbiome is scarce. We aimed to characterize the effect of rosuvastatin on gut microbiome composition and inferred genetic content in stool samples from a randomized controlled trial (n?=?66). No taxa were significantly altered by rosuvastatin during the study. However, rosuvastatin-treated participants showed a reduction in the collective genetic potential to transport and metabolize precursors of the pro-atherogenic metabolite trimethylamine-N-oxide (TMAO, p?

SUBMITTER: Kummen M 

PROVIDER: S-EPMC7096534 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature